Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Somru BioScience gets $4M
‘This is really about strengthening the local ecosystem’ Source: CBC..
Read More ...Bioanalytical Challenges of Biosimilars
Challenges and Solutions Seminar Series Register now: http://www.somrubioscience.com/page/somru-seminar Ready to..
Read More ...Philanthropy
This feature is coming soon! The unparalleled team of technological entrepreneurs at..
Read More ...Amplatto
Amplatto Applications Ultra-sensitive bioanalysis, ADA, low dose PK Information Femtomolar..
Read More ...